Top Markets
#1 DogBull DogBull +54.98%
#2 Siren Siren +30.99%
#3 OriginTrail OriginTrail +18.04%
#4 Ethena Staked ENA Ethena Staked ENA +10.57%
#5 龙虾 (Lobster) 龙虾 (Lobster) +10.13%
#6 Stargate Finance Stargate Finance +9.23%
#7 Cysic Cysic +8.42%
#8 Ether.fi Ether.fi +8.25%
#9 UnifAI Network UnifAI Network +8.12%
#10 Collect on Fanable Collect on Fanable +7.85%
Coin of the day
DogBull DogBull
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
AlzeCure Pharma AB AlzeCure Pharma AB

AlzeCure Pharma AB

ALZCUR
Classement en actions #22112
AlzeCure Pharma AB (publ) operates as a pharmaceutical company that develops... AlzeCure Pharma AB (publ) operates as a pharmaceutical company that develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The company is involved in the development of drug candidates based on the NeuroRestore, Alzstatin, and Painless research platforms. Its products pipeline includes ACD856 for the treatment of Alzheimer’s disease, sleep disorders, depression, traumatic brain injuries, and Parkinson’s disease, which is in phase I clinical trial; ACD857, ACD679, and ACD680 that are in preclinical trial for the treatment of Alzheimer’s disease; ACD440, a TRPV1 antagonist that has completed phase I clinical trial for neuropathic pain indications; and ACD137, negative allosteric modulator (NAM) of TrkA receptors for osteoarthritic pain indications. The company was founded in 2012 and is based in Huddinge, Sweden.
Prix de l'action
$0.71707249
Dernière synchronisation: 2026-08-21
Capitalisation boursière
$94.14M
Changement (1 jour)
-3.31%
Changement (1 an)
76.82%
Pays
SE
Échange AlzeCure Pharma AB (ALZCUR)

Catégorie

Healthcare
Revenus pour AlzeCure Pharma AB (ALZCUR)
Revenus en Aug 2026 TTM : 0
Selon les derniers rapports financiers de AlzeCure Pharma AB, le chiffre d'affaires actuel de l'entreprise (TTM) est de 0. En 2026, l'entreprise a réalisé un chiffre d'affaires de 0 égal à le chiffre d'affaires de l'année 2026, qui était de 0. Le chiffre d'affaires correspond au revenu total généré par la vente de biens ou de services. Contrairement au bénéfice, aucune dépense n'est déduite.
Historique des revenus pour AlzeCure Pharma AB de 2026 à 2026
Revenus à la fin de chaque année
Année Revenus Changez
Pas assez de données pour les dates fournies.
Revenus d’entreprises similaires ou concurrentes
Entreprise Revenus Différence de revenus Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH